Latest Publications

Share:

COVID-19 Weekly Newsletter: Cases Rise for First Time in Two Months, Global Vaccine Tracker Unveiled

A global vaccine tracker is unveiled as cases are on the rise for the first time in two months. With herd immunity unlikely at this point, researchers are developing the next generation of COVID-19 vaccines. COVID Cases...more

COVID-19 Weekly Newsletter: Vaccine Approved for Children, OSHA Vaccination Mandate

Efforts to continue to promote and expand access to COVID-19 vaccines reached major milestones this week, as the holiday season draws near. OSHA Vaccination Mandate - In early September, President Biden released a...more

COVID-19 Weekly Newsletter: Average Case Rates Drop From Delta Wave’s Heights

This week’s newsletter details the latest developments in the process of approving COVID-19 vaccines for children ages 5-11, a vaccine that produced promising clinical results, and new studies revealing insights about...more

COVID-19 Weekly Newsletter: Additional Booster Shots Recommended as FDA Prepares to Evaluate Vaccines for Younger Children

Booster Shot Endorsements - Last week, the U.S. Food and Drug Administration (FDA) advisory committee endorsed one of the mRNA COVID-19 vaccines and the single-dose vaccine to be used as a booster shot. This week, FDA...more

COVID-19 Weekly Newsletter: FDA Considers COVID-19 Pill, Travel Restrictions To Be Lifted

A new submission for a Food and Drug Administration (FDA) emergency use authorization (EUA), new guidance for travelers entering the U.S. and continued studies into the efficacy of booster shots headlined this week’s...more

COVID-19 Weekly Newsletter: A Pill To Treat COVID-19?

A promising new COVID-19 treatment grabbed headlines this week, along with new updates on one mRNA vaccine manufacturer’s path to potentially seeking Food and Drug Administration (FDA) approval on vaccines for children...more

COVID-19 Weekly Newsletter: Domestic and International Vaccine News

Clinical trials and public health recommendations relating to booster vaccines and potential vaccines for children under the age of 12 continue to be front and center in the United States’ domestic COVID-19 response....more

COVID-19 Weekly Newsletter: Updates on Vaccines for Children and Potential Authorization for Booster Shots

Amid continued spread of the Delta variant and sobering new studies about the toll COVID-19 has exacted on medical staff, vaccine manufacturers and public health leaders continue to seek solutions — including efforts to...more

COVID-19 Weekly Newsletter: Biden Announces New Pandemic Plan

On September 9, President Biden announced a new six-pronged plan to address COVID-19, which includes bold steps aimed at increasing vaccination rates. Biden’s Path Out of the Pandemic Plan - On Thursday, President...more

The American Telemedicine Association Again Leads the Industry Commenting on Medicare Updates to Telehealth Policy

Faegre Drinker professionals Sarah-Lloyd Stevenson, Megan Herber, Nisha Quasba and Libby Baney provide ongoing support to the American Telemedicine Association’s (ATA) policy work. This month, the comment period for the...more

COVID-19 Weekly Newsletter: EU Restricts Travel, U.S. Boosts Vaccine Supply Chain

The European Union removed the U.S. from its safe travel list earlier this week, as the Biden administration took measures to bolster the vaccine supply chain to meet the anticipated rise in demand. Children Account for...more

COVID-19 Weekly Newsletter: Full FDA Approval

The COVID-19 vaccine approval process reached a major milestone, but the fourth U.S. wave of the COVID-19 virus has prompted some sobering projections about the future of the pandemic. COVID-19 Vaccine Receives Full FDA...more

COVID-19 Weekly Newsletter: Booster Shots Continue To Gain Steam

Recent announcements on the prospect of booster shots for all vaccinated Americans, a vaccine mandate for staff at federally funded nursing homes and an encouraging uptick in vaccinations marked an eventful week in the...more

COVID-19 Weekly Newsletter: Response to Delta Variant Intensifies

FDA Authorizes Booster Shots for Immunocompromised - The United States Food and Drug Administration updated its emergency use authorizations for two currently authorized COVID-19 vaccines on Thursday, sanctioning third...more

COVID-19 Weekly Newsletter: Formidable Delta Variant Prompts Vaccine Mandates

Vaccinated Individuals Infected With Delta Variant May Carry as Much Virus as Unvaccinated - The U.S. Centers for Disease Control and Prevention (CDC) updated their mask guidance on July 27, 2021, recommending that...more

COVID-19 Weekly Newsletter: CDC Updates Guidance

New federal guidance on masking and testing highlighted an eventful week in the COVID-19 response, as government authorities work to respond to the rising transmission of the Delta variant. CDC Updates Masking and...more

COVID-19 Weekly Newsletter: Combating the Delta Variant

As the Delta variant becomes more prevalent — and its severity better understood — public health authorities look to apply lessons from earlier waves of the COVID-19 pandemic to help curb the recent rise in cases. The latest...more

COVID-19 Weekly Newsletter: Cases on the Rise in All 50 States

Cases on the Rise in All 50 States This week marks the first time in months that all 50 states are seeing a rise in cases, with more than 30 states seeing at least a 50% increase over the previous week. The U.S. Centers for...more

COVID-19 Weekly Newsletter: Variant Reduces Vaccine Efficacy but There Is Disagreement on Need for Boosters

Vaccine Manufacturer and Government Agencies Disagree on Need for Booster Shots - A manufacturer of an mRNA COVID-19 vaccine stated they are observing decreased immunity from its vaccine and issued a statement saying they...more

COVID-19 Weekly Newsletter: Variants and Vaccine Hesitancy

As the delta variant becomes more prominent in the U.S., public health authorities look for ways to address vaccine hesitancy, and the scientific community seeks to better understand viruses — as our list of identified...more

COVID-19 Weekly Newsletter: Delta Variant a Threat to the Unvaccinated

Delta Variant Accounts for 20% of Samples Tested - The delta variant, first identified in India a few months ago and now present in 90-plus countries, is more transmissible and deadly than previous variants that have...more

Long-Awaited 21st Century Cures Act 2.0 Draft Released

Following months of anticipation by stakeholders including patient organizations, research institutions and medical product developers, Representatives Fred Upton (R-MI) and Diana DeGette (D-DO) released a 21st Century Cures...more

COVID-19 Weekly Newsletter: Pandemic Restrictions Are Disappearing

Restrictions put in place to halt the spread of COVID-19 are disappearing across the U.S. as states reach vaccination goals, while the search for effective COVID-19 therapeutics to treat the disease and prevent future...more

COVID-19 Weekly Newsletter: Preparing for Post-Pandemic Life

With employers, schools and other organizations considering or carrying out reopening procedures, the focus for health and safety authorities turns to maintaining a low-risk environment for the public. While OSHA addresses...more

COVID-19 Weekly Newsletter: U.S. Vaccination Effort Goes International

While actively launching new initiatives and incentives to boost the vaccination rate within its own population, the U.S. government this week announced its plans to share portions of its vaccine stockpile...more

71 Results
 / 
View per page
Page: of 3

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide